These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 37857423)

  • 1. Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry.
    McDowell PJ; McDowell R; Busby J; Eastwood MC; Patel PH; Jackson DJ; Mansur A; Patel M; Burhan H; Doe S; Chaudhuri R; Gore R; Dodd JW; Subramanian D; Brown T; Heaney LG;
    Eur Respir J; 2023 Dec; 62(6):. PubMed ID: 37857423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab.
    Menzies-Gow A; Hoyte FL; Price DB; Cohen D; Barker P; Kreindler J; Jison M; Brooks CL; Papeleu P; Katial R
    Adv Ther; 2022 May; 39(5):2065-2084. PubMed ID: 35287231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Response and Remission in Patients With Severe Asthma Treated With Biologic Therapies.
    Hansen S; Baastrup Søndergaard M; von Bülow A; Bjerrum AS; Schmid J; Rasmussen LM; Johnsen CR; Ingebrigtsen T; Håkansson KEJ; Johansson SL; Bisgaard M; Assing KD; Hilberg O; Ulrik C; Porsbjerg C
    Chest; 2024 Feb; 165(2):253-266. PubMed ID: 37925144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients.
    Thomas D; McDonald VM; Stevens S; Harvey ES; Baraket M; Bardin P; Bowden JJ; Bowler S; Chien J; Chung LP; Gillman A; Hew M; Hodge S; James A; Jenkins C; Katelaris CH; Katsoulotos GP; Langton D; Lee J; Marks G; Peters M; Radhakrishna N; Reynolds PN; Rimmer J; Sivakumaran P; Upham JW; Wark P; Yang IA; Gibson PG
    Allergy; 2024 Feb; 79(2):384-392. PubMed ID: 37632144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of sex on severe asthma: a cross-sectional retrospective analysis of UK primary and specialist care.
    Loewenthal L; Busby J; McDowell R; Brown T; Burhan H; Chaudhuri R; Dennison P; Dodd JW; Doe S; Faruqi S; Gore R; Idris E; Jackson DJ; Patel M; Pantin T; Pavord I; Pfeffer PE; Price DB; Rupani H; Siddiqui S; Heaney LG; Menzies-Gow A;
    Thorax; 2024 Apr; 79(5):403-411. PubMed ID: 38124220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort.
    Milger K; Suhling H; Skowasch D; Holtdirk A; Kneidinger N; Behr J; Timmermann H; Schulz C; Schmidt O; Ehmann R; Hamelmann E; Idzko M; Taube C; Lommatzsch M; Buhl R; Korn S
    J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2701-2712.e2. PubMed ID: 37301433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic burden of severe asthma among US patients treated with biologic therapies.
    Reibman J; Tan L; Ambrose C; Chung Y; Desai P; Llanos JP; Moynihan M; Tkacz J
    Ann Allergy Asthma Immunol; 2021 Sep; 127(3):318-325.e2. PubMed ID: 33775904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologics for severe asthma and beyond.
    Mümmler C; Milger K
    Pharmacol Ther; 2023 Dec; 252():108551. PubMed ID: 37907197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients.
    Valverde-Monge M; Sánchez-Carrasco P; Betancor D; Barroso B; Rodrigo-Muñoz JM; Mahillo-Fernández I; Arismendi E; Bobolea I; Cárdaba B; Cruz MJ; Del Pozo V; Domínguez-Ortega J; González-Barcala FJ; Olaguibel JM; Luna-Porta JA; Martínez-Rivera C; Mullol J; Muñoz X; Peleteiro-Pedraza L; Picado Valles C; Plaza V; Quirce S; Rial MJ; Soto-Retes L; Valero A; Sastre J
    Arch Bronconeumol; 2024 Jan; 60(1):23-32. PubMed ID: 38042707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologics for severe asthma-Which, when and why?
    Shah PA; Brightling C
    Respirology; 2023 Aug; 28(8):709-721. PubMed ID: 37222237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring Definitions and Predictors of Severe Asthma Clinical Remission Post-Biologic in Adults.
    Perez-de-Llano L; Scelo G; Tran TN; Le TT; Fagerås M; Cosio BG; Peters M; Pfeffer PE; Al-Ahmad M; Al-Lehebi RO; Altraja A; Bergeron C; Bjermer LH; Bjerrum AS; Bulathsinhala L; Busby J; Cano Rosales DJ; Canonica GW; Carter VA; Charriot J; Christoff GC; Denton EJ; Dorscheid DR; Fernandez Sanchez MJ; Fonseca JA; Gibson PG; Goh CYY; Heaney LG; Heffler E; Hew M; Iwanaga T; Katial R; Koh MS; Kuna P; Larenas-Linnemann DES; Lehtimäki L; Mahboub B; Martin N; Matsumoto H; Menzies-Gow AN; Papadopoulos NG; Popov TA; Porsbjerg CM; Patel P; Rhee CK; Sadatsafavi M; Taillé C; Torres-Duque CA; Tsai MJ; Ulrik CS; Upham JW; von Bülow A; Wang E; Wechsler ME; Price DB
    Am J Respir Crit Care Med; 2024 May; ():. PubMed ID: 38701495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological therapy management from the initial selection of biologics to switching between biologics in severe asthma.
    Yılmaz İ; Paçacı Çetin G; Arslan B; Şeker S; Bozkurt Yılmaz HE; Aktaş Yapıcı E; Köylüce S; Açar E
    Tuberk Toraks; 2023 Mar; 71(1):75-93. PubMed ID: 36912412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-Life Response to Biologics in Severe Asthma with Nasal Polyposis: Insights from the Belgian Severe Asthma Registry.
    Demolder F; Vanderhelst E; Verbanck S; Schleich F; Louis R; Brusselle G; Sohy C; Michils A; Peché R; Pilette C; Hanon S
    Lung; 2024 Aug; 202(4):441-448. PubMed ID: 39007944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asthma biologics: Real-world effectiveness, impact of switching biologics, and predictors of response.
    Abbas F; Georas S; Cai X; Khurana S
    Ann Allergy Asthma Immunol; 2021 Dec; 127(6):655-660.e1. PubMed ID: 34481992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era.
    Jackson DJ; Busby J; Pfeffer PE; Menzies-Gow A; Brown T; Gore R; Doherty M; Mansur AH; Message S; Niven R; Patel M; Heaney LG;
    Thorax; 2021 Mar; 76(3):220-227. PubMed ID: 33298582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical remission with biologic therapies in severe asthma: a matter of definition.
    ; McDowell PJ; McDowell R; Busby J; Eastwood MC; Patel PH; Jackson DJ; Mansur A; Patel M; Burhan H; Doe S; Chaudhuri R; Gore R; Dodd JW; Subramanian D; Brown T; Heaney LG
    Eur Respir J; 2024 Jun; 63(6):. PubMed ID: 38901893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in severe asthma patients receiving biologics and factors associated with persistent insufficient control: a real-life national study.
    Guilleminault L; Camus C; Raherison-Semjen C; Capdepon A; Bourdin A; Bonniaud P; Fry S; Devouassoux G; Blanc FX; Pison C; Dupin C; Khayath N; Courdeau J; Valcke-Brossollet J; Nocent-Ejnaini C; Rolland F; Lamandi C; Proust A; Ozier A; Portel L; Gaspard W; Roux-Claude P; Beurnier A; Martinez S; Dot JM; Hennegrave F; Vignal G; Auvray E; Paleiron N; Just N; Miltgen J; Russier M; Olivier C; Taillé C; Didier A
    Ther Adv Respir Dis; 2023; 17():17534666231202749. PubMed ID: 37966015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethnic Differences in Severe Asthma Clinical Care and Outcomes: An Analysis of United Kingdom Primary and Specialist Care.
    Busby J; Heaney LG; Brown T; Chaudhuri R; Dennison P; Gore R; Jackson DJ; Mansur AH; Menzies-Gow A; Message S; Niven R; Patel M; Price D; Siddiqui S; Stone R; Pfeffer PE;
    J Allergy Clin Immunol Pract; 2022 Feb; 10(2):495-505.e2. PubMed ID: 34626858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors to Consider in Prescribing Asthma Biologic Therapies to Children.
    Anderson WC; Banzon TM; Chawes B; Papadopoulos NG; Phipatanakul W; Szefler SJ
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):693-701. PubMed ID: 36646381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and functional remission: even though biologics are superior to conventional DMARDs overall success rates remain low--results from RABBIT, the German biologics register.
    Listing J; Strangfeld A; Rau R; Kekow J; Gromnica-Ihle E; Klopsch T; Demary W; Burmester GR; Zink A
    Arthritis Res Ther; 2006; 8(3):R66. PubMed ID: 16600016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.